期刊文献+

Pirh2、p53的相互关系及其在恶性肿瘤中的作用 被引量:1

在线阅读 下载PDF
导出
出处 《医学临床研究》 CAS 2007年第7期1214-1217,共4页 Journal of Clinical Research
基金 湖南省卫生厅科研基金课题资助(编号B2005-021)
  • 相关文献

参考文献24

  • 1Roger P.Leng,Yunping Lin,Weili Ma,et al.Pirh2,a p53induced ubiquitin-protein ligase,promotes p53 degradation[J].Cell,2003;112(6):779-791.
  • 2Logan IR,Sapountzi V,Gaughan L,et al.Control of human PIRH2 protein stability:involvement of TIP60 and the proteosome[J].J Biol Chem,2004,279(12):11696-11704.
  • 3L.K.Beitel,Y.A.Elhaji,R.Lumbroso,et al.Cloning and characterization of an androgen receptor N-terminal-interacting protein with ubiquitin-protein ligase activity[J].J Mol Endocrinol,2002;29(1):41-60.
  • 4Batsakis JG,EL-Naggar AK.P53:fifteen years after discovery[J].Advan Anat Pathol,1995;2:71.
  • 5Halevy O.Different tumor-derived P53 mutants exhibit distinct biological activities[J].Science,1990;250:113.
  • 6Marchetti P,Cannita K,Ricevuto E,et al.Prognostic value of P53 molecular status in high risk primary breast cancer[J].Ann Oncol,2003,14(5):704-708.
  • 7Sangrajran S,Arpornwirat W,Cheirsilpa A,et al.Serum p53 antibodies incorrelation to other biologieal parameters of breast cancer[J].Cancer Detect Prev,2003,27(3):182-186.
  • 8Linjawi A,Kontogiannea M,Halwani F,et al.Prognostic significance of p53,bcl-2,and Bax expression in early breast cancer[J].J Am Coll Surg,2004,198(1):83-90.
  • 9Duan W,Oao L,Druhan LJ,et al.Expression of Pirh2,a newly identified ubiquitin protein ligase,in lung cancer[J].J Natl Cancer Inst,2004,96(22):1718-1721.
  • 10Harris SL,Levine Aj.The P53 pathway:positive and negative feedback loops[J].Oacogene,2005,18,24(17):2899.

二级参考文献7

  • 1Tao W, Levine AJ. Nucleocytoplasmic shuttling of oncoprotein Hdm2 is required for Hdm2-mediated degradation of p53. Proc Natl Acad Sci USA, 1999,96:3077-3080.
  • 2Yu ZK, Geyer RK, Maki CG. MDM2-dependent ubiquitination of nuclear and cytoplasmic p53. Oncogene,2000,119:5892-5897.
  • 3Xirodimas DP, Stephen CW, Lane DP. Cocompartmentalization of p53 and MDM2 is a major determinant for MDM2-mediated degradation of p53. Exp Cell Res,2001,270:66-77.
  • 4Zhang Y, Xiong Y. A p53 amino-terminal nuclear export signal inhibited by DNA damage-induced phosphorylation. Science,2001,292:1910.
  • 5Liang S-H, Clarke MF. A bipartite nuclear localization signal is required for p53 nuclear import regulated by a carboxyl-terminal domain. J Biol Chem, 1999,274: 32699-32703.
  • 6Stommel JM, Marchenko ND, Jimene GS, et al. A leucine-rich nuclear export signal in the p53 tetramerization domain: regulation of subcellular localization and p53 activity by NES masking. EMBO J, 1999,18: 1660- 1672.
  • 7Blattner C, Hay T, Meek DW, et al. Hypophosphorylation of MDM2 augments p53 stability. Mol Cell Biol, 2002,22:6170-6182.

共引文献7

同被引文献19

  • 1Hainaut P, WimanKG. 30 years and a long way into p53 re- search[ J]. Lancet 0ncol,2009,10(9) :913 -919.
  • 2Leng PR,Lin Y,MA W. Pirh2 ,a p53 - induced ubiqutin - protein ligase, promtes p53 degradation [ J ]. Cell, 2003,112 (6) :779 -791.
  • 3Logan I R, Sapountzi V, Gaughanl, et al. Control of human PIRH2 protein stbility: involvement of Tip60 and the prote- odome[ J]. J Biol Chem,2004,279(12) :11696 - 11704.
  • 4Linzer DL,Levrne AJ. Characterization of a 54K surviv cel- lular SV40 tumor antigen present in SV40 -transformed cells and uninfected embryonal carcinoma cells [ J ]. Cell, 1979,19(1) :43 -45.
  • 5Vogelstein B, Lane D, Levine A. Surfing the p53 network [ J ]. Nature,2000,408 (6810) : 307 - 310.
  • 6Morita N,Ikeda Y,Takami H. Clinical significance of p53 protein expression in papillary thyoid carcinoma [ J ]. World J surg,2008 ,32 :2617 - 2622.
  • 7张学良,王华.甲状腺癌肿瘤标志物及相关基因研究进展[J].交通医学,2008,22(2):132-136. 被引量:4
  • 8张珊文.中国p53基因治疗的现状和前景[J].医学研究杂志,2008,37(6):3-5. 被引量:13
  • 9王承红.p53基因在肿瘤放疗中的研究进展[J].医学综述,2010,16(2):205-207. 被引量:19
  • 10陈青,邬黎青.p53基因和乳腺癌的相关性研究进展[J].实验与检验医学,2011,29(1):57-59. 被引量:9

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部